Advertisement
Screener

OPKO Health, Inc. (OPK) Gain (Loss) on Investments

1.5 / 5 stars · 26/87 Roast Me

OPKO Health, Inc. Gain (Loss) on Investments

OPKO Health, Inc. (OPK) reported Gain (Loss) on Investments of -$3.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossOnInvestments · last filed 2024-11-07

  • OPKO Health, Inc. gain (loss) on investments for the quarter ending 2024-09-30 was -$3.00K.
  • OPKO Health, Inc. gain (loss) on investments for the quarter ending 2024-06-30 was -$1.00K.
  • OPKO Health, Inc. gain (loss) on investments for the quarter ending 2024-03-31 was -$3.00K.
  • OPKO Health, Inc. gain (loss) on investments for the quarter ending 2023-12-31 was -$8.00K.
  • OPKO Health, Inc. gain (loss) on investments for fiscal 2023 was -$107.00K.
  • OPKO Health, Inc. gain (loss) on investments for fiscal 2022 was -$383.00K.
  • OPKO Health, Inc. gain (loss) on investments for fiscal 2021 was -$629.00K.
  • OPKO Health, Inc. gain (loss) on investments for fiscal 2020 was -$480.00K.
Period endGain (Loss) on Investments 3 monthGain (Loss) on Investments 6 monthGain (Loss) on Investments 9 monthGain (Loss) on Investments 12 month
2024-09-30-$3.00K
10-Q · filed 2024-11-07
-$4.00K
derived: sum of 2 quarters · filed 2024-11-07
-$7.00K
10-Q · filed 2024-11-07
-$15.00K
derived: sum of 4 quarters · filed 2024-11-07
2024-06-30-$1.00K
10-Q · filed 2024-08-07
-$3.00K
10-Q · filed 2024-08-07
-$12.00K
derived: sum of 3 quarters · filed 2024-08-07
-$32.00K
derived: sum of 4 quarters · filed 2024-11-07
2024-03-31-$3.00K
10-Q · filed 2024-05-07
-$11.00K
derived: sum of 2 quarters · filed 2024-05-07
-$31.00K
derived: sum of 3 quarters · filed 2024-11-07
-$73.00K
derived: sum of 4 quarters · filed 2024-11-07
2023-12-31-$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
-$28.00K
derived: sum of 2 quarters · filed 2024-11-07
-$70.00K
derived: sum of 3 quarters · filed 2024-11-07
-$107.00K
10-K · filed 2024-03-01
2023-09-30-$20.00K
10-Q · filed 2024-11-07
-$62.00K
derived: sum of 2 quarters · filed 2024-11-07
-$99.00K
10-Q · filed 2024-11-07
-$123.00K
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$42.00K
10-Q · filed 2024-08-07
-$79.00K
10-Q · filed 2024-08-07
-$103.00K
derived: sum of 3 quarters · filed 2024-08-07
-$146.00K
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$37.00K
10-Q · filed 2024-05-07
-$61.00K
derived: sum of 2 quarters · filed 2024-05-07
-$104.00K
derived: sum of 3 quarters · filed 2024-05-07
-$372.00K
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31-$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
-$67.00K
derived: sum of 2 quarters · filed 2024-03-01
-$335.00K
derived: sum of 3 quarters · filed 2024-03-01
-$383.00K
10-K · filed 2024-03-01
2022-09-30-$43.00K
10-Q · filed 2023-11-06
-$311.00K
derived: sum of 2 quarters · filed 2023-11-06
-$359.00K
10-Q · filed 2023-11-06
-$826.00K
derived: sum of 4 quarters · filed 2024-03-01
2022-06-30-$268.00K
10-Q · filed 2023-08-03
-$316.00K
10-Q · filed 2023-08-03
-$783.00K
derived: sum of 3 quarters · filed 2024-03-01
-$836.00K
derived: sum of 4 quarters · filed 2024-03-01
2022-03-31-$49.00K
10-Q · filed 2023-05-03
-$515.00K
derived: sum of 2 quarters · filed 2024-03-01
-$568.00K
derived: sum of 3 quarters · filed 2024-03-01
-$635.00K
derived: sum of 4 quarters · filed 2024-03-01
2021-12-31-$466.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
-$519.00K
derived: sum of 2 quarters · filed 2024-03-01
-$586.00K
derived: sum of 3 quarters · filed 2024-03-01
-$629.00K
10-K · filed 2024-03-01
2021-09-30-$53.00K
10-Q · filed 2022-11-08
-$120.00K
derived: sum of 2 quarters · filed 2022-11-08
-$163.00K
10-Q · filed 2022-11-08
-$210.00K
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$67.00K
10-Q · filed 2022-08-04
-$110.00K
10-Q · filed 2022-08-04
-$157.00K
derived: sum of 3 quarters · filed 2023-02-27
-$267.00K
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31-$43.00K
10-Q · filed 2022-05-09
-$90.00K
derived: sum of 2 quarters · filed 2023-02-27
-$200.00K
derived: sum of 3 quarters · filed 2023-02-27
-$389.00K
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$47.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
-$157.00K
derived: sum of 2 quarters · filed 2023-02-27
-$346.00K
derived: sum of 3 quarters · filed 2023-02-27
-$480.00K
10-K · filed 2023-02-27
2020-09-30-$110.00K
10-Q · filed 2021-10-28
-$299.00K
derived: sum of 2 quarters · filed 2021-10-28
-$433.00K
10-Q · filed 2021-10-28
-$914.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$189.00K
10-Q · filed 2021-07-29
-$323.00K
10-Q · filed 2021-07-29
-$804.00K
derived: sum of 3 quarters · filed 2022-03-01
-$1.10M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$134.00K
10-Q · filed 2021-04-28
-$615.00K
derived: sum of 2 quarters · filed 2022-03-01
-$909.00K
derived: sum of 3 quarters · filed 2022-03-01
-$1.18M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$481.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$775.00K
derived: sum of 2 quarters · filed 2022-03-01
-$1.05M
derived: sum of 3 quarters · filed 2022-03-01
-$2.90M
10-K · filed 2022-03-01
2019-09-30-$294.00K
10-Q · filed 2020-10-29
-$565.00K
derived: sum of 2 quarters · filed 2020-10-29
-$2.42M
10-Q · filed 2020-10-29
-$5.37M
derived: sum of 4 quarters · filed 2021-02-18
2019-06-30-$271.00K
10-Q · filed 2020-07-31
-$2.13M
10-Q · filed 2020-07-31
-$5.08M
derived: sum of 3 quarters · filed 2021-02-18
-$6.95M
derived: sum of 4 quarters · filed 2021-02-18
2019-03-31-$1.85M
10-Q · filed 2020-05-06
-$4.81M
derived: sum of 2 quarters · filed 2021-02-18
-$6.68M
derived: sum of 3 quarters · filed 2021-02-18
-$13.90M
derived: sum of 4 quarters · filed 2021-02-18
2018-12-31-$2.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18
-$4.83M
derived: sum of 2 quarters · filed 2021-02-18
-$12.04M
derived: sum of 3 quarters · filed 2021-02-18
-$14.50M
10-K · filed 2021-02-18
2018-09-30-$1.87M
10-Q · filed 2019-11-05
-$9.09M
derived: sum of 2 quarters · filed 2019-11-05
-$11.54M
10-Q · filed 2019-11-05
-$14.24M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$7.21M
10-Q · filed 2019-08-07
-$9.67M
10-Q · filed 2019-08-07
-$12.37M
derived: sum of 3 quarters · filed 2020-03-02
-$16.38M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$2.46M
10-Q · filed 2019-05-08
-$5.16M
derived: sum of 2 quarters · filed 2020-03-02
-$9.17M
derived: sum of 3 quarters · filed 2020-03-02
-$14.80M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$2.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$6.71M
derived: sum of 2 quarters · filed 2020-03-02
-$12.34M
derived: sum of 3 quarters · filed 2020-03-02
-$14.47M
10-K · filed 2020-03-02
2017-09-30-$4.01M
10-Q · filed 2018-11-09
-$9.64M
derived: sum of 2 quarters · filed 2018-11-09
-$11.77M
10-Q · filed 2018-11-09
-$14.28M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30-$5.63M
10-Q · filed 2018-08-07
-$7.76M
10-Q · filed 2018-08-07
-$10.26M
derived: sum of 3 quarters · filed 2019-03-01
-$11.08M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$2.13M
10-Q · filed 2018-05-08
-$4.64M
derived: sum of 2 quarters · filed 2019-03-01
-$5.45M
derived: sum of 3 quarters · filed 2019-03-01
-$7.44M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$3.32M
derived: sum of 2 quarters · filed 2019-03-01
-$5.31M
derived: sum of 3 quarters · filed 2019-03-01
-$7.65M
10-K · filed 2019-03-01
2016-09-30-$814.00K
10-Q · filed 2017-11-08
-$2.80M
derived: sum of 2 quarters · filed 2017-11-08
-$5.15M
10-Q · filed 2017-11-08
-$6.18M
derived: sum of 4 quarters · filed 2019-01-29
2016-06-30-$1.99M
10-Q · filed 2017-08-08
-$4.33M
10-Q · filed 2017-08-08
-$5.37M
derived: sum of 3 quarters · filed 2019-01-29
-$8.87M
derived: sum of 4 quarters · filed 2019-01-29
2016-03-31-$2.35M
10-Q · filed 2017-05-10
-$3.38M
derived: sum of 2 quarters · filed 2019-01-29
-$6.88M
derived: sum of 3 quarters · filed 2019-01-29
-$7.69M
derived: sum of 4 quarters · filed 2019-01-29
2015-12-31-$1.04M
derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29
-$4.54M
derived: sum of 2 quarters · filed 2019-01-29
-$5.34M
derived: sum of 3 quarters · filed 2019-01-29
-$7.11M
8-K · filed 2019-01-29
2015-09-30-$3.50M
10-Q · filed 2016-11-07
-$4.31M
derived: sum of 2 quarters · filed 2016-11-07
-$6.07M
10-Q · filed 2016-11-07
-$7.17M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30-$804.00K
10-Q · filed 2016-08-08
-$2.56M
10-Q · filed 2016-08-08
-$3.67M
derived: sum of 3 quarters · filed 2017-03-01
-$3.73M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$1.76M
10-Q · filed 2016-05-09
-$2.86M
derived: sum of 2 quarters · filed 2017-03-01
-$2.92M
derived: sum of 3 quarters · filed 2017-03-01
-$3.29M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$1.16M
derived: sum of 2 quarters · filed 2017-03-01
-$1.53M
derived: sum of 3 quarters · filed 2017-03-01
-$3.59M
10-K · filed 2017-03-01
2014-09-30-$60.00K
10-Q · filed 2015-11-09
-$430.00K
derived: sum of 2 quarters · filed 2015-11-09
-$2.49M
10-Q · filed 2015-11-09
2014-06-30-$370.00K
10-Q · filed 2015-08-05
-$2.43M
10-Q · filed 2015-08-05
2014-03-31-$2.06M
10-Q · filed 2015-05-11
2013-12-31-$11.46M
10-K · filed 2016-02-29
2013-06-30-$2.37M
10-Q · filed 2013-08-09
-$6.26M
10-Q · filed 2013-08-09
-$6.86M
derived: sum of 3 quarters · filed 2015-02-27
-$7.33M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$3.89M
10-Q · filed 2013-05-10
-$4.49M
derived: sum of 2 quarters · filed 2015-02-27
-$4.96M
derived: sum of 3 quarters · filed 2015-02-27
-$5.43M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$598.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$1.07M
derived: sum of 2 quarters · filed 2015-02-27
-$1.54M
derived: sum of 3 quarters · filed 2015-02-27
-$2.06M
10-K · filed 2015-02-27
2012-09-30-$468.00K
10-Q · filed 2012-11-09
-$943.00K
derived: sum of 2 quarters · filed 2013-08-09
-$1.46M
10-Q · filed 2012-11-09
-$1.88M
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30-$475.00K
10-Q · filed 2013-08-09
-$996.00K
10-Q · filed 2013-08-09
-$1.41M
derived: sum of 3 quarters · filed 2014-03-03
-$1.71M
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31-$523.00K
10-Q · filed 2013-05-10
-$937.00K
derived: sum of 2 quarters · filed 2014-03-03
-$1.24M
derived: sum of 3 quarters · filed 2014-03-03
-$1.69M
derived: sum of 4 quarters · filed 2014-03-03
2011-12-31-$414.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
-$715.00K
derived: sum of 2 quarters · filed 2014-03-03
-$1.17M
derived: sum of 3 quarters · filed 2014-03-03
-$1.59M
10-K · filed 2014-03-03
2011-09-30-$301.00K
10-Q · filed 2012-11-09
-$752.00K
derived: sum of 2 quarters · filed 2012-08-09
-$1.18M
10-Q · filed 2012-11-09
-$1.21M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$451.00K
10-Q · filed 2012-08-09
-$874.00K
10-Q · filed 2012-08-09
-$905.00K
derived: sum of 3 quarters · filed 2013-03-18
-$1.11M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$423.00K
10-Q · filed 2012-05-10
-$454.00K
derived: sum of 2 quarters · filed 2013-03-18
-$662.00K
derived: sum of 3 quarters · filed 2013-03-18
-$906.00K
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31-$31.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$239.00K
derived: sum of 2 quarters · filed 2013-03-18
-$483.00K
derived: sum of 3 quarters · filed 2013-03-18
-$714.00K
10-K · filed 2013-03-18
2010-09-30-$208.00K
10-Q · filed 2011-11-09
-$452.00K
derived: sum of 2 quarters · filed 2011-11-09
-$683.00K
10-Q · filed 2011-11-09
2010-06-30-$244.00K
10-Q · filed 2011-08-08
-$475.00K
10-Q · filed 2011-08-08
2009-12-31-$353.00K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
HARROW, INC. (HROW)United States$1.240B-42.77
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93